Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Substance P and somatostatin neurons limit facial itch by recruiting distinct nociceptive circuits in the brainstem. | Commun Biol | 2026 | 42069949 | PubTator, text mining | PubMed |
| Cetirizine suppresses cancer-associated fibroblast-mediated fibrotic remodeling and epithelial-mesenchymal transition via histamine H1 receptor inverse agonism. | Breast Cancer Res | 2026 | 42036667 | PubTator, text mining | PubMed |
| A neuroimmune axis linking S100A8/9 to itch sensitization in both bullous pemphigoid and atopic dermatitis. | JID Innov | 2026 | 42022890 | PubTator, text mining | PubMed |
| A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptor. | Mol Divers | 2026 | 41966669 | PubTator, text mining | PubMed |
| Quantitative deciphering of mammalian histamine receptors through mathematical genomics. | Biochem Biophys Res Commun | 2026 | 41946080 | PubTator, text mining | PubMed |
| Corrigendum to "Histamine H1 receptor: a potential therapeutic target for pancreatic ductal adenocarcinoma". | J Pharmacol Exp Ther | 2026 | 41945988 | PubTator, text mining | PubMed |
| Genetically-predicted placental gene expression links to uterine fibroids and endometriosis. | Placenta | 2026 | 41936293 | PubTator, text mining | PubMed |
| Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. | J Mol Med (Berl) | 2026 | 41917502 | PubTator, text mining | PubMed |
| Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms. | World J Exp Med | 2026 | 41883453 | PubTator, text mining | PubMed |
| MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression. | Clin Exp Med | 2026 | 41866561 | PubTator, text mining | PubMed |
| Specific GPCRs elicit unique extracellular vesicle miRNA array signatures. | Elife | 2026 | 41860956 | PubTator, text mining | PubMed |
| A Potential Central Hub of Histamine in the Microbiota-Gut-Joint Axis in Rheumatoid Arthritis: Mechanisms and Translational Implications. | Int J Mol Sci | 2026 | 41828539 | PubTator, text mining | PubMed |
| Rhabdomyolysis secondary to chlorpheniramine maleate toxicity: a case report. | Front Pharmacol | 2026 | 41800096 | PubTator, text mining | PubMed |
| Studies and analysis of drug-target interactions by affinity chromatography and related techniques: A review. | J Pharm Anal | 2026 | 41798072 | PubTator, text mining | PubMed |
| Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implications. | Neurooncol Adv | 2026 | 41768124 | PubTator, text mining | PubMed |
| Latest surface plasmon resonance advances for G protein-coupled receptors. | J Pharm Anal | 2026 | 41767747 | PubTator, text mining | PubMed |
| Adverse events associated with tirzepatide: a focus on subgroup-specific differences. | BMC Pharmacol Toxicol | 2026 | 41742317 | PubTator, text mining | PubMed |
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment. | Open Life Sci | 2026 | 41737604 | PubTator, text mining | PubMed |
| Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. | World Allergy Organ J | 2026 | 41732343 | PubTator, text mining | PubMed |
| Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study. | Br J Clin Pharmacol | 2026 | 41724883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=2